Royalty Pharma
Mr. Grofik joined Royalty Pharma in 2020. Previously, he served as VP, Head of Global Investor Relations at Sanofi. Prior to joining Sanofi, Mr. Grofik was the senior equity research analyst at Citi covering the U.S. large-cap pharmaceutical industry. He is a CFA®charterholder and holds a BS in accounting from Binghamton University.
Royalty Pharma
3 followers
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies.